These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15047101)

  • 1. Structure and mechanism of NAD[P]H:quinone acceptor oxidoreductases (NQO).
    Bianchet MA; Faig M; Amzel LM
    Methods Enzymol; 2004; 382():144-74. PubMed ID: 15047101
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of NAD(P)H:quinone reductase: Ab initio studies of reduced flavin.
    Cavelier G; Amzel LM
    Proteins; 2001 Jun; 43(4):420-32. PubMed ID: 11340659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the quinone reductase activity of the ferric reductase B protein from Paracoccus denitrificans.
    Sedlácek V; van Spanning RJ; Kucera I
    Arch Biochem Biophys; 2009 Mar; 483(1):29-36. PubMed ID: 19138657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulator of drug activity B from Escherichia coli: crystal structure of a prokaryotic homologue of DT-diaphorase.
    Adams MA; Jia Z
    J Mol Biol; 2006 Jun; 359(2):455-65. PubMed ID: 16630630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural and synthetic quinones and their reduction by the quinone reductase enzyme NQO1: from synthetic organic chemistry to compounds with anticancer potential.
    Colucci MA; Moody CJ; Couch GD
    Org Biomol Chem; 2008 Feb; 6(4):637-56. PubMed ID: 18264564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of NAD(P)H:quinone acceptor oxidoreductase by flavones: a structure-activity study.
    Chen S; Hwang J; Deng PS
    Arch Biochem Biophys; 1993 Apr; 302(1):72-7. PubMed ID: 8470908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase).
    Zhao Q; Yang XL; Holtzclaw WD; Talalay P
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1669-74. PubMed ID: 9050836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A site-directed mutagenesis study at Lys-113 of NAD(P)H:quinone-acceptor oxidoreductase: an involvement of Lys-113 in the binding of the flavin adenine dinucleotide prosthetic group.
    Tedeschi G; Deng PS; Chen HH; Forrest GL; Massey V; Chen S
    Arch Biochem Biophys; 1995 Aug; 321(1):76-82. PubMed ID: 7639539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Nad(P)h: quinone oxidoreductase in the regulation of intracellular redox state.
    Mohora M
    Rom J Intern Med; 2000-2001; 38-39():33-50. PubMed ID: 15529570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and mechanism of cytosolic quinone reductases.
    Bianchet MA; Foster C; Faig M; Talalay P; Amzel LM
    Biochem Soc Trans; 1999 Aug; 27(4):610-5. PubMed ID: 10917652
    [No Abstract]   [Full Text] [Related]  

  • 11. A two-domain structure for the two subunits of NAD(P)H:quinone acceptor oxidoreductase.
    Chen S; Deng PS; Bailey JM; Swiderek KM
    Protein Sci; 1994 Jan; 3(1):51-7. PubMed ID: 7511454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutually inhibitory feedback loop between the 20S proteasome and its regulator, NQO1.
    Moscovitz O; Tsvetkov P; Hazan N; Michaelevski I; Keisar H; Ben-Nissan G; Shaul Y; Sharon M
    Mol Cell; 2012 Jul; 47(1):76-86. PubMed ID: 22793692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the mechanism of Type-II NADH: Quinone oxidoreductase from S. aureus.
    Sena FV; Sousa FM; Oliveira ASF; Soares CM; Catarino T; Pereira MM
    Redox Biol; 2018 Jun; 16():209-214. PubMed ID: 29524843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAD(P)H quinone oxidoreductase (NQO1): an enzyme which needs just enough mobility, in just the right places.
    Pey AL; Megarity CF; Timson DJ
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30518535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined molecular modelling and 3D-QSAR study for understanding the inhibition of NQO1 by heterocyclic quinone derivatives.
    López-Lira C; Alzate-Morales JH; Paulino M; Mella-Raipán J; Salas CO; Tapia RA; Soto-Delgado J
    Chem Biol Drug Des; 2018 Jan; 91(1):29-38. PubMed ID: 28643389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction.
    Li R; Bianchet MA; Talalay P; Amzel LM
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8846-50. PubMed ID: 7568029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel quinolinequinone antitumor agents: structure-metabolism studies with NAD(P)H:quinone oxidoreductase (NQO1).
    Fryatt T; Pettersson HI; Gardipee WT; Bray KC; Green SJ; Slawin AM; Beall HD; Moody CJ
    Bioorg Med Chem; 2004 Apr; 12(7):1667-87. PubMed ID: 15028260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and partial purification of microsomal NAD(P)H:quinone oxidoreductases.
    Jaiswal AK
    Arch Biochem Biophys; 2000 Mar; 375(1):62-8. PubMed ID: 10683249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of human quinone reductase type 2, a metalloflavoprotein.
    Foster CE; Bianchet MA; Talalay P; Zhao Q; Amzel LM
    Biochemistry; 1999 Aug; 38(31):9881-6. PubMed ID: 10433694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAD(P)H:menadione oxidoreductase of the amitochondriate eukaryote Giardia lamblia: a simpler homologue of the vertebrate enzyme.
    Sánchez LB; Elmendorf H; Nash TE; Müller M
    Microbiology (Reading); 2001 Mar; 147(Pt 3):561-570. PubMed ID: 11238963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.